510(k) · Cleared

Cleared

IS Ebv-Ebna-1 Igg Elisa Test System

K981829510(k) TraditionalCleared Feb 16, 1999270-day reviewClass I21 CFR 866.3235

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diamedix Corp. · GNP Antiserum, Cf, Epstein-Barr Virus

Cleared on Feb 16, 1999 after a 270-day review. The FDA summary names its predicate without a number.

Decided: Feb 16, 1999
Review: 270 days
Class: Class I
Product code: GNP
Recalls: None
Predicates: 0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K981829Source: FDA 510(k) database · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GNP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Candidate predicates for a device like this, rankedin the report
Recall history across each candidate’s familyin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	—	Wampole EBNA-1 IgG ELISA Named without a submission number			—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GNP devices

GNP Antiserum, Cf, Epstein-Barr Virus: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GNP

FDA has decided no GNP device since 2007.

Median 510(k) review, days · GNP

Too few GNP 510(k)s in any year since 2007 to give a median.

Recalls per year · GNP

No recall names GNP since 2007.

Adverse event reports per year · GNP

No MAUDE report names GNP since 2007.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

What is it indicated for?

Read the full statement (122 words)

The & EBNA-1 IgG - kit is an Enzyme-Linked Immunosorbent Assay (ELISA) For the qualitative and semi-quantitative determination of IgG antibodies to Epstein-Barr Virus (recombinant) Nuclear Antigen-1 (EBV-EBNA-1 IgG) in human serum by indirect enzyme immunoassay. The Is-EBV-EBNA-1 IgG Test Kit may be used in combination with other Epstein-Barr serologies (Viral Capsid Antigen (VCA) IgG and IgM , Epstein-Barr Nuclear Antigen-1 (EBNA-1) IgM, Early Antigen-Diffuse (EA-D) IgG and IgM and heterophile antibody as an aid in the diagnosis of infectious mononucleosis (IM). The evaluation of paired sera, to determine a significant increase in EBNA-1 IgG antibody titer, can also aid in the diagnosis of acute infection. These reagents can be used either manually or in conjunction with the MAGO® Plus Automated Processor.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K981829 · printed Nov 4, 2026

Cite this page

510(k) Report. “K981829: IS Ebv-Ebna-1 Igg Elisa Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K981829

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Page last updated Nov 3, 2026